Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-220811
Filing Date
2013-05-15
Accepted
2013-05-15 06:26:03
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d515658d10q.htm 10-Q 327542
2 EX-31.1 d515658dex311.htm EX-31.1 6333
3 EX-31.2 d515658dex312.htm EX-31.2 6327
4 EX-32.1 d515658dex321.htm EX-32.1 4347
5 EX-32.2 d515658dex322.htm EX-32.2 4341
  Complete submission text file 0001193125-13-220811.txt   3269544

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fcsc-20130331.xml EX-101.INS 430377
7 XBRL TAXONOMY EXTENSION SCHEMA fcsc-20130331.xsd EX-101.SCH 39872
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fcsc-20130331_cal.xml EX-101.CAL 46474
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fcsc-20130331_def.xml EX-101.DEF 106960
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fcsc-20130331_lab.xml EX-101.LAB 283177
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fcsc-20130331_pre.xml EX-101.PRE 208668
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31564 | Film No.: 13843630
SIC: 2834 Pharmaceutical Preparations